Abstract
The common carotid artery (CCA) supplies intra- and extra-cranial vascular beds. An area in the medulla controlling CCA blood flow is defined as the dorsal facial area (DFA) by Kuo et al. in 1987. In the DFA, presynaptic nitrergic and/or glutamatergic fibers innervate preganglionic nitrergic and/or cholinergic neurons which give rise to the preganglionic fibers of the parasympathetic 7th and 9th cranial nerves. Released glutamate from presynaptic nitrergic and/or glutamatergic fibers can activate N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid (AMPA) receptors on preganglionic nitrergic and/or cholinergic neurons. By modulating this glutamate release, several neurochemicals including serotonin, arginine, nitric oxide, nicotine, choline and ATP in the DFA regulate CCA blood flow. Understanding the neurochemical regulatory mechanisms can provide important insights of the physiological roles of the DFA, and may help develop therapeutic strategies for diseases involving CCA blood flow, such as migraine, hypertensive disease, Alzheimer’s disease and cerebral ischemic stroke.
Keywords: Carotid artery, Cerebral blood flow, Medulla, Parasympathetic nucleus, Vascular regulation, Neurotransmitter
Current Neuropharmacology
Title:Neurochemicals Involved in Medullary Control of Common Carotid Blood Flow
Volume: 11 Issue: 5
Author(s): Chi-Li Gong, Yuk-Man Leung, Ming-Ren Wang, Nai-Nu Lin, Tony Jer-Fu Lee and Jon-Son Kuo
Affiliation:
Keywords: Carotid artery, Cerebral blood flow, Medulla, Parasympathetic nucleus, Vascular regulation, Neurotransmitter
Abstract: The common carotid artery (CCA) supplies intra- and extra-cranial vascular beds. An area in the medulla controlling CCA blood flow is defined as the dorsal facial area (DFA) by Kuo et al. in 1987. In the DFA, presynaptic nitrergic and/or glutamatergic fibers innervate preganglionic nitrergic and/or cholinergic neurons which give rise to the preganglionic fibers of the parasympathetic 7th and 9th cranial nerves. Released glutamate from presynaptic nitrergic and/or glutamatergic fibers can activate N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid (AMPA) receptors on preganglionic nitrergic and/or cholinergic neurons. By modulating this glutamate release, several neurochemicals including serotonin, arginine, nitric oxide, nicotine, choline and ATP in the DFA regulate CCA blood flow. Understanding the neurochemical regulatory mechanisms can provide important insights of the physiological roles of the DFA, and may help develop therapeutic strategies for diseases involving CCA blood flow, such as migraine, hypertensive disease, Alzheimer’s disease and cerebral ischemic stroke.
Export Options
About this article
Cite this article as:
Gong Chi-Li, Leung Yuk-Man, Wang Ming-Ren, Lin Nai-Nu, Lee Jer-Fu Tony and Kuo Jon-Son, Neurochemicals Involved in Medullary Control of Common Carotid Blood Flow, Current Neuropharmacology 2013; 11 (5) . https://dx.doi.org/10.2174/1570159X113119990044
DOI https://dx.doi.org/10.2174/1570159X113119990044 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Patents on Therapeutic and Cosmetic Applications of Bioactives of Crocus Sativus L. and their Production through Synthetic Biology Methods: A Review
Recent Patents on Biotechnology Cardioprotective Potential of Iron Chelators and Prochelators
Current Medicinal Chemistry Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Food-derived Bioactive Peptides - Opportunities for Designing Future Foods
Current Pharmaceutical Design Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews NADPH Oxidase and Neurodegeneration
Current Neuropharmacology Molecular Hydrogen Application in Stroke: Bench to Bedside
Current Pharmaceutical Design Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research Retinal Vascular Features for Cardio Vascular Disease Prediction: A Review
Recent Patents on Computer Science Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3)
Current Neurovascular Research Invasive and Noninvasive Assessment of Exercise-induced Ischemic Diastolic Response Using Pressure Transducers
Current Cardiology Reviews Coarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Similarities and Differences Between Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Angiogenic Imbalance as a Contributor of Preeclampsia
Current Pharmaceutical Biotechnology Lower Uric Acid Linked with Cognitive Dysfunction in the Elderly
CNS & Neurological Disorders - Drug Targets Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design